Three patients with spinal muscular atrophy had improved muscle strength and could walk farther after a month of daily spinal ...

Researchers reported a spine-stimulating implant might aid neurodegenerative diseases like spinal muscle atrophy.

A new drug-free, minimally invasive intervention targets the root cause of progressive loss of neural function in spinal muscle atrophy (SMA), an inherited neuromuscular disease.

A Boston-area biopharmaceutical firm has submitted a biologics license application to the FDA for its investigational, fully ...

An experimental treatment that stimulates the spinal cord may help people with a paralyzing genetic disorder called spinal muscular atrophy.

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy (SMA), cardiometabolic ...

Spinraza (nusinersen) is a prescription drug used to treat spinal muscular atrophy. Spinraza can cause side effects that range from mild to serious. Examples include headache and fever.

Analytics company GlobalData has shared its optimism regarding the future of Novartis’ spinal muscular atrophy (SMA ... compared to other treatments on the market. These include Biogen ...

Seeking urgent Union government intervention to overcome the lack of affordable access to medicines for treating Spinal Muscular Atrophy (SMA ... Currently three treatments are available for ...

What is SPINRAZA and its current approval status? SPINRAZA is an approved treatment for spinal muscular atrophy in over 71 countries, currently delivered at a dose of 12 mg. Disclaimer ...